Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα
- 20 May 1999
- journal article
- Published by Springer Nature in Oncogene
- Vol. 18 (20) , 3063-3070
- https://doi.org/10.1038/sj.onc.1202893
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 34 references indexed in Scilit:
- Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.Journal of Clinical Investigation, 1997
- NF-κB: Ten Years AfterCell, 1996
- 2 Pathophysiology of Hodgkin's disease: functional and molecular aspectsBailliere's Clinical Haematology, 1996
- PrefaceBailliere's Clinical Haematology, 1996
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- CD30 Ligand, a Member of the TNF Ligand Superfamily, with Growth and Activation Control for CD30+ Lymphoid and Lymphoma Cells*Leukemia & Lymphoma, 1996
- Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice.Genes & Development, 1995
- Inducible Nuclear Expression of Newly Synthesized IκBα Negatively Regulates DNA-Binding and Transcriptional Activities of NF-κBMolecular and Cellular Biology, 1995
- Autoregulation of I kappa B alpha activity.Proceedings of the National Academy of Sciences, 1994
- Recent Results on the Biology of Hodgkin and Reed-Sternberg cells: II. Continuous Cell LinesLeukemia & Lymphoma, 1993